Philips announced a voluntary recall of some of its sleep and respiratory care devices in mid-June. The U.S. Food and Drug Administration (FDA) announced the…
Read MoreFirm News: Page 3
Category: Our Firm
W&L Is One of Firms Filing Most Product Liability Cases
Weitz & Luxenberg ranks second among the top plaintiffs’ law firms filing the most product liability cases, according to recent analysis. Between 2018 and…
Category: Drugs & Devices
W&L Attorney Gold Appointed to Elmiron MDL Leadership
Attorney Danielle Gold has been appointed to serve on the Plaintiffs’ Executive Committee in the Elmiron multidistrict litigation (MDL). The litigation alleges that taking…
Category: Our Firm
Kraft Speaks at Contemporary Issues in Mass Torts
Weitz & Luxenberg trial attorney Danny Kraft, Jr. is one of the presenters scheduled for an upcoming seminar sponsored by the New Jersey Institute…
Category: Drugs & Devices
W&L Taking Penumbra Recalled JET 7 Catheters with Xtra Flex Technology Cases
According to the U.S. Food and Drug Administration (FDA), the medical device manufacturer Penumbra issued an urgent voluntary recall of the Penumbra JET 7…
Category: Mesothelioma, Our Firm
W&L Attorneys Participate in N.Y. Asbestos Litigation Conference
This year’s New York Asbestos Conference was co-chaired by Charles Ferguson, chair of Weitz & Luxenberg’s Mesothelioma and Asbestos Practice Group. Three other attorneys…